TABLE 1.
Entry | His6-Substrate | Antibiotic Activity | Synthetase Activitya (Relative to WT) |
---|---|---|---|
1 | wt | + | ++ |
2 | E-13A | + | ++ |
3 | E-8P | +b | - |
4 | E-8A | ND | ++ |
5 | L-7E | +b | - |
6 | L-7K | - | - |
7 | L-7A | ND | + |
8 | D-6G | + | ++ |
9 | D-6P | ND | - |
10 | L-5P | ND | + |
11 | L-5Q | + | ++ |
12 | I-4G | + | ND |
13 | I-4P | ND | - |
14 | G-2V | + | ++ |
15 | G-2K | + | ++ |
16 | G-2E | + | ND |
17 | A-1I | + | ND |
18 | A-1K | + | ++ |
19 | A-1D | + | ND |
20 | A-1G | ND | ++ |
All mutants shown in entries 1-20 underwent four dehydrations when incubated for 12 h except for L-7K. The designations +, ++, and - refer to the following phenotypes of the mutant substrates when monitoring the time-dependence of dehydration by LctM. Mutants that were fully processed to a four-fold dehydrated product in a similar timespan as wt-LctA are indicated with ++. Mutants that were processed by LctM into a mixture of three- and fourfold dehydrated peptides in this time span are indicated with +. These mutants can be converted to fourfold dehydrated products upon longer incubation times. Mutants that were processed to predominantly three-fold dehydrated products without ever going to complete fourfold dehydrated products are indicated with -. ND, biological activity not determined (column 3) or not investigated in a time-dependent fashion (column 4).
Bioactivity was only observed when at least some fourfold dehydrated product was produced.